# Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

> **NCT04713631** · PHASE2 · UNKNOWN · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Curcumin
- **DRUG:** Placebo A
- **DRUG:** Placebo C

## Key facts

- **NCT ID:** NCT04713631
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-21
- **Primary completion:** 2023-12
- **Final completion:** 2024-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713631, "Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04713631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*